These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32727824)

  • 1. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
    Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
    Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.
    Vyas AR; Singh SV
    AAPS J; 2014 Jan; 16(1):1-10. PubMed ID: 24046237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy fails to alter withaferin A-mediated lethality in human breast cancer cells.
    Hahm ER; Singh SV
    Curr Cancer Drug Targets; 2013 Jul; 13(6):640-50. PubMed ID: 23607597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
    Lee J; Hahm ER; Marcus AI; Singh SV
    Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells.
    Hahm ER; Lee J; Huang Y; Singh SV
    Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
    Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
    J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.
    Antony ML; Lee J; Hahm ER; Kim SH; Marcus AI; Kumari V; Ji X; Yang Z; Vowell CL; Wipf P; Uechi GT; Yates NA; Romero G; Sarkar SN; Singh SV
    J Biol Chem; 2014 Jan; 289(3):1852-65. PubMed ID: 24297176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
    Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
    J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withaferin A: From Ancient Remedy to Potential Drug Candidate.
    Sultana T; Okla MK; Ahmed M; Akhtar N; Al-Hashimi A; Abdelgawad H; Haq IU
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
    Lee J; Sehrawat A; Singh SV
    Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin A of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor.
    Ali MA; Farah MA; Al-Anazi KM; Basha SH; Bai F; Lee J; Al-Hemaid FMA; Mahmoud AH; Hailan WAQ
    Curr Pharm Biotechnol; 2020; 21(9):842-851. PubMed ID: 31995002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
    Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
    J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
    [No Abstract]   [Full Text] [Related]  

  • 13. Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
    Xia S; Miao Y; Liu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2363-2369. PubMed ID: 29966656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
    Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
    BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug.
    Hassannia B; Logie E; Vandenabeele P; Vanden Berghe T; Vanden Berghe W
    Biochem Pharmacol; 2020 Mar; 173():113602. PubMed ID: 31404528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.
    Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC
    Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Dutta R; Khalil R; Green R; Mohapatra SS; Mohapatra S
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withaferin A in the Treatment of Liver Diseases: Progress and Pharmacokinetic Insights.
    Xia Y; Yan M; Wang P; Hamada K; Yan N; Hao H; Gonzalez FJ; Yan T
    Drug Metab Dispos; 2022 May; 50(5):685-693. PubMed ID: 34903587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cancer activity of withaferin A in B-cell lymphoma.
    McKenna MK; Gachuki BW; Alhakeem SS; Oben KN; Rangnekar VM; Gupta RC; Bondada S
    Cancer Biol Ther; 2015; 16(7):1088-98. PubMed ID: 26020511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo.
    Stan SD; Hahm ER; Warin R; Singh SV
    Cancer Res; 2008 Sep; 68(18):7661-9. PubMed ID: 18794155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.